Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors

Clinical trial NCT07586826 · RECRUITING

Trial details

NCT number: NCT07586826
Sponsor: Peking University People's Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Persistent Isolated Chemotherapy-Induced Thrombocytopenia Chemotherapy-Induced Thrombocytopenia Gynecologic Cancers Ovarian Cancer Breast Cancer Lung Cancer Non-Small Cell Lung Cancer Cervical Cancer Fallopian Tube Cancer Primary Peritoneal Cancer

Start date: 2025-12-22
Primary completion: 2027-10-31
Enrollment: 220

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.